Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02582489 · ClinicalTrials.gov registry record · NA
Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy
A NA study of Osteoarthritis Post-meniscectomy, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02582489: Recruiting NA study of Osteoarthritis Post-meniscectomy, sponsored by Rush University Medical Center.
NCT02582489 is a NA study of Osteoarthritis Post-meniscectomy that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02582489, a NA study of Osteoarthritis Post-meniscectomy, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare patient-reported outcomes, specifically IKDC scores between patients who receive BMAC post-meniscectomy and those who receive a saline control injection. The study will also compare physical examination, MRI, radiographs, and synovial fluid analysis. Our hypothesis is that those who receive the autologous BMAC injection after the procedure will have better outcomes than those who do not.
Primary Outcome
The primary outcome measure will be the IKDC score at one year follow-up
Conditions Studied
Interventions
- BIOLOGICAL Bone Marrow Aspirate Concentrate
- PROCEDURE Standard Meniscectomy
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-12-22 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT02582489 shows while recruiting
NCT02582489 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Osteoarthritis Post-meniscectomy appearing as the primary indexed condition, and to 2 interventions - of which Bone Marrow Aspirate Concentrate is the first listed.
NCT02582489 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02582489 about?
NCT02582489 is a clinical study titled "Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy". The proposed research study aims to evaluate the effects of autologous bone marrow aspirate concentrate (BMAC) on the development and progression of osteoarthritis (OA) in patients undergoing meniscectomy. This prospective, randomized, double-blind clinical trial will compare patient-reported outcom...
What is the current status of trial NCT02582489?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-12-22. Estimated completion is 2026-12-31.
What conditions does trial NCT02582489 study?
This clinical trial studies the following conditions: Osteoarthritis Post-meniscectomy.
What interventions are being tested in trial NCT02582489?
The interventions under investigation include: Bone Marrow Aspirate Concentrate (BIOLOGICAL), Standard Meniscectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02582489?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02582489 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02582489's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI